Latest News:
  • FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
  • TIF will coordinate efforts for patients’ information on Reblozyl in 62 countries
  • New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019
  • Deferasirox Mylan: A new generic drug for the treatment of iron overload in β-thalassaemia major obtained approval by the EMA
  • US government & Gates Foundation pledge $200 million to bring gene therapies to patients with Sickle Cell Disease & HIV
ardeelenfrit

TIFTIF

  • About
  • Education
  • Country work
  • Positions & Policies
  • Projects
  • Publications
  • News & Events
  • Contact
Home » Publications » TIF e-Newsletter

TIF e-Newsletter

2019

September
June
April

2017

December

2016

January
February
March
April

2015

January
February
March
April
May
June
July
September
October
November

2014

January
February
March
April
May
June
July
August
September
October
November
December

2013

January
February
March
April
May
September
October
November
December

2012

December
2017-08-06
tifwp

Quick Links

  • For Patients
  • For Healthcare Professionals
  • For Associations
  • For Supporters
  • Our Members
  • Useful Links
  • Sitemap

Quick links

  • For Patients
  • For Healthcare Professionals
  • For Associations
  • For Supporters
  • Our Members
  • Useful Links
  • Sitemap

Design & Development

Featured Video

More videos

Subscribe to our newsletter

Download the Apps

ThaliMe App


Transparency Statement | Privacy Policy

Copyright TIF © 2019

Cookies

This site uses cookies. Find out more